Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel L Aitken

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Jac-Antimicrobial Resistance|August 16, 2023
#AMRrounds: a systematic educational approach for navigating bench to bedside antimicrobial resistanceElaine Liu, Andrea M Prinzi, Jovan Borjan, et al.
Journal of Pharmacy Practice|December 28, 2017
Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory ConcentrationsJerry Altshuler, David J Guervil, Charles D Ericsson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 8, 2025
How do I manage a patient with Stenotrophomonas maltophilia infection?Roberta Monardo, Maria F Mojica, Marco Ripa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2019
Levofloxacin versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell TransplantationVi P Doan, Jason C Yeh, Alison M Gulbis, et al.
Open Forum Infectious Diseases|November 25, 2024
A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive Care Units: Unit-Specific Combination Antibiograms Versus Patient-Specific Risk FactorsWalaiporn Wangchinda, Samuel L Aitken, Megan E Klatt, et al.
Leukemia & Lymphoma|June 13, 2020
Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinibMichael Frei, Samuel L Aitken, Nitin Jain, et al.
Epidemiology and Infection|May 10, 2018
Outcomes associated with Clostridium difficile infection in patients with chronic liver diseaseKierra M Dotson, Samuel L Aitken, Amelia K Sofjan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia InfectionsPranita D Tamma, Samuel L Aitken, Robert A Bonomo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant RecipientsFarnaz Foolad, Samuel L Aitken, Terri Lynn Shigle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2021
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Jac-Antimicrobial Resistance|August 16, 2023
#AMRrounds: a systematic educational approach for navigating bench to bedside antimicrobial resistanceElaine Liu, Andrea M Prinzi, Jovan Borjan, et al.
Journal of Pharmacy Practice|December 28, 2017
Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory ConcentrationsJerry Altshuler, David J Guervil, Charles D Ericsson, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 8, 2025
How do I manage a patient with Stenotrophomonas maltophilia infection?Roberta Monardo, Maria F Mojica, Marco Ripa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2019
Levofloxacin versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell TransplantationVi P Doan, Jason C Yeh, Alison M Gulbis, et al.
Open Forum Infectious Diseases|November 25, 2024
A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive Care Units: Unit-Specific Combination Antibiograms Versus Patient-Specific Risk FactorsWalaiporn Wangchinda, Samuel L Aitken, Megan E Klatt, et al.
Leukemia & Lymphoma|June 13, 2020
Incidence and characterization of fungal infections in chronic lymphocytic leukemia patients receiving ibrutinibMichael Frei, Samuel L Aitken, Nitin Jain, et al.
Epidemiology and Infection|May 10, 2018
Outcomes associated with Clostridium difficile infection in patients with chronic liver diseaseKierra M Dotson, Samuel L Aitken, Amelia K Sofjan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2021
Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia InfectionsPranita D Tamma, Samuel L Aitken, Robert A Bonomo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 12, 2018
Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant RecipientsFarnaz Foolad, Samuel L Aitken, Terri Lynn Shigle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2021
Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)Pranita D Tamma, Samuel L Aitken, Robert A Bonomo, et al.
Pageof 11